NL-OMON20380招募中不适用
ate Effects and Follow up after pediatric hematological stem cell transplantation and cell therapy (LEEF)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- one
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- •>2 years after pediatric HSCT for non-malignant diseases
- •Written informed consent by the patient or legal guardians, and pediatric consent when indicated
排除标准
- •A potential subject who meets any of the following criteria will be excluded from participation in this study:
- •Any medical or social reasons, which obstruct or inhibit study participation according to the treating physician;
- •Patient or legal guardians unable or unwilling to give consent, or lack of pediatric consent when indicated.
研究者
相似试验
尚未招募
3 期
A clinical trial to test the use of a drug called Romiplostim in children after stem cell transplantation for early platelet recoveryCTRI/2024/03/064716I
招募中
不适用
A prospective study of pediatric hereditary hematological disordersPediatric hereditary hematological disordersJPRN-UMIN000037774agoya university1,000
尚未招募
不适用
ong-term hematopoiesis in transplantation survivorsAllogeneic Hematopoietic Stem Cell TransplantationNL-OMON20624Prinses Máxima Center for Pediatric Oncology150
招募中
不适用
ong-term integrity of hematopoiesis in pediatric stem cell transplantation survivorsHematopoietic stem cell transplantationbone marrow transplantation1000208610027665NL-OMON54142Prinses Máxima Centrum voor Kinderoncologie375
尚未招募
Unknown
Evaluation of children with post septic sequelae of hip jointCTRI/2023/09/057407O SPONSOR